Izotropic Corporation (FRA:1R3)

Market Cap	9.23M +45.9%
Revenue (ttm)	n/a
Net Income	-1.70M
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	100
Open	0.1125
Previous Close	0.1260
Day's Range	0.1125 - 0.1125
52-Week Range	0.1000 - 0.2800
Beta	n/a
RSI	46.05
Earnings Date	Apr 2, 2026

About Izotropic

Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360‐degree image acquisition and can be used with or without injectable contrast. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2016
• Country: Canada
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1R3

Financial Performance

Financial numbers in CAD